Novartis - Health Technology Insights

Health Tech Insights: Latest News And Innovations – Roundup

Health Technology Insights: Latest News And Innovations – Roundup

August 12, 2025

Welcome to your Daily Dose of Health Tech Innovation!Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.We bring you expert-curated insights,

Novartis Ianalumab Trials Succeed in Sjögren’s Disease

August 11, 2025

NEPTUNUS-1 and NEPTUNUS-2 are the first ever global Phase III trials to demonstrate statistically significant reduction in disease activity for Sjögren’s disease Novartis announced positive

Novartis Completes Acquisition Of Regulus Therapeutics

June 25, 2025

Novartis announced that it has successfully completed its acquisition of Regulus Therapeutics Inc. With the completion of the acquisition, shares of common stock, par value

Categories

Tag: Novartis

Health Technology Insights: Latest News And Innovations – Roundup

Novartis Ianalumab Trials Succeed in Sjögren’s Disease

Novartis Completes Acquisition Of Regulus Therapeutics

Share With

Recent Posts

ZeOmega and Clearlink Partners Unite to Streamline Delegated Clinical Services

Inspiren Names Brian Geyser Head of Clinical Innovation for AI

TraceLink Boosts Supply Chain with New AI-Powered OPUS Tools

Nanosonics Launches Latest Innovation for High-Level Disinfection of Ultrasound Probes

Vital User Count Surges Past 5-Million Patients, Expected to Triple by 2026

Quick Links

Insights

Get in touch

Follow Us

Our Other Brands